Mutational mechanisms of EZH2 inactivation in myeloid neoplasms

EZH2, a component of the polycomb repressive complex 2, catalyses the trimethylation of histone H3 lysine 27, a chromatin mark associated with transcriptional repression. EZH2 loss-of-function mutations are seen in myeloid neoplasms and are associated with an adverse prognosis. Missense mutations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chase, Andrew, Score, Joannah, Lin, Feng, Bryant, Catherine, Waghorn, Katherine, Yapp, Sarah, Carreno-Tarragona, Gonzalo, Aranaz, Paula, Villasante, Aranzazu, Ernst, Thomas, Cross, Nicholas C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610374/
https://www.ncbi.nlm.nih.gov/pubmed/32322039
http://dx.doi.org/10.1038/s41375-020-0816-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610374/
https://www.ncbi.nlm.nih.gov/pubmed/32322039
http://dx.doi.org/10.1038/s41375-020-0816-y

Ejemplares similares